New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection FractionGlobeNewsWire • 05/14/24
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024GlobeNewsWire • 05/09/24
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/02/24
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 05/02/24
Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon PharmaceuticalsGlobeNewsWire • 04/29/24
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & ExpoGlobeNewsWire • 03/25/24
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/11/24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 03/11/24
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity SecuritiesGlobeNewsWire • 03/11/24
Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/29/24
3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street AnalystsThe Motley Fool • 01/31/24
Lexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant ValueSeeking Alpha • 01/04/24
Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare ConferenceGlobeNewsWire • 12/21/23
Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)GlobeNewsWire • 11/30/23
Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx ConferenceGlobeNewsWire • 11/22/23
INPEFA® (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical DataGlobeNewsWire • 11/12/23
Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceGlobeNewsWire • 11/10/23